At last....and excellent critique of the way too often cited '17 year gap'.

Mmm. 4am in Australia. Will a recording be available please?

Would love to hear this. Will a recording be available for those of us on the other side of the world?

Indeed. Graphical representations showing 'benefits' don't really reflect the fact that observed differences aren't really clinically meaningful. Australia's TGA hasn't approved lecanemab although has approved donanemab (why?). PBS approval unlikely but pending.

All very difficult for patients and carers to get their heads around.

I look forward to seeing this.

Beautiful pics but may need explanation for those of us without inside knowledge!!

Sounds excellent. Very much needed.

People first.
Patients - in context.
But...'consumers' - please, never!!!

A great meeting. Thanks for the invitation!

Excellent initiative. Take note funding bodies in Australia!

Ethical approval generally not necessary if the role is an advisory/partnership role.

Sounds like a good idea to do so! What are your plans re how you will involve them and how you will find the right people?

Looks interesting

A good question. Public contributors to research benefit greatly from attending conferences and make valuable contributions to conferences. Reduced registration fees help. Unless funding built into research project budget, not easy to get funds to cover full costs - in my experience.